| Identification | Back Directory | [Name]
6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one | [CAS]
2095417-54-0 | [Synonyms]
6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-iMidazo[1,2-c]pyriMidin-5-one | [Molecular Formula]
C15H19N3O6 | [MDL Number]
MFCD28125305 | [MOL File]
2095417-54-0.mol | [Molecular Weight]
337.328 |
| Hazard Information | Back Directory | [Uses]
6-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-3-(2-oxopropyl)imidazo[1,2-c]pyrimidin-5(6H)-one is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
|